Prevalence and outcome of congenital heart disease in patients with neural tube defect

Basit Öğe Kaydı
dc.authoridYologlu, Saim/0000-0002-9619-3462
dc.authoridKARAKURT, CEMŞIT/0000-0002-9246-8107
dc.authorwosidYologlu, Saim/ABI-8014-2020
dc.authorwosidKARAKURT, CEMŞIT/ABE-2330-2020
dc.contributor.authorKocak, Guelendam
dc.contributor.authorOnal, Cagatay
dc.contributor.authorKocak, Ayham
dc.contributor.authorKarakurt, Cemsit
dc.contributor.authorAtes, Oezkan
dc.contributor.authorCayli, Sueleyman R.
dc.contributor.authorYologlu, Saim
dc.date.accessioned2024-08-04T20:30:47Z
dc.date.available2024-08-04T20:30:47Z
dc.date.issued2008
dc.departmentİnönü Üniversitesien_US
dc.description.abstractA prospective clinical study was designed to establish the risk factors, the prevalence, and the progress of congenital heart defects in children with neural tube defects. Study included 90 children with a mean age of 13.5 +/- 30.4 months. There were 53 (59%) patients with spina bifida occulta and 37 (41%) patients with spina bifida aperta. The overall prevalence of congenital heart disease was 27.8% (40.5% in spina bifida aperta and 18.9% in spina bifida occulta; P = .024). There was no statistically significant difference for maternal age, usage of periconceptional folate, and maternal diabetes between the patient and control groups. The authors conclude that congenital heart defects are more common than reported in neural tube defects, and screening echocardiograms are warranted. This should be kept in mind especially in patients requiring minor or major surgical procedures. Furthermore, routine obstetric examination and therefore the use of periconceptional folic acid during pregnancy is still lacking in our country.en_US
dc.identifier.doi10.1177/0883073807309789
dc.identifier.endpage530en_US
dc.identifier.issn0883-0738
dc.identifier.issue5en_US
dc.identifier.pmid18056696en_US
dc.identifier.scopus2-s2.0-42449087324en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage526en_US
dc.identifier.urihttps://doi.org/10.1177/0883073807309789
dc.identifier.urihttps://hdl.handle.net/11616/94512
dc.identifier.volume23en_US
dc.identifier.wosWOS:000255299600008en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofJournal of Child Neurologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectneural tube defecten_US
dc.subjectcongenital heart defecten_US
dc.titlePrevalence and outcome of congenital heart disease in patients with neural tube defecten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu